RecruitingNCT07038239
Genotype/Phenotype Correlation of MORC2 Mutations
Studying Autosomal dominant Charcot-Marie-Tooth disease type 2 with giant axons
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Hospices Civils de Lyon
- Intervention
- Skin biopsy(diagnostic_test)
- Enrollment
- 45 enrolled
- Eligibility
- 4 years · All sexes
- Timeline
- 2025 – 2027
Study locations (12)
- CHU de Besançon, Besançon, France
- CHRU Brest, Brest, France
- CHU Grenoble, Grenoble, France
- CH de Versailles, Le Chesnay, France
- Service de Génétique moléculaire, pharmacogénétique, hormologie Hôpital Bicêtre, Le Kremlin-Bicêtre, France
- Hospices Civils de Lyon, Lyon, France
- CHU Marseille, Marseille, France
- CHU de Nantes, Nantes, France
- CH Pitié Salpêtrière, Paris, France
- Hôpital Necker, Paris, France
- CHU de Saint-Etienne, Saint-Etienne, France
- CHU Strasbourg, Strasbourg, France
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT07038239 on ClinicalTrials.govOther trials for Autosomal dominant Charcot-Marie-Tooth disease type 2 with giant axons
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT06203093Charcot-Marie-Tooth Disease (CMT) Biological Sample Collection for IPSC Generation and BiobankingNew York Stem Cell Foundation Research Institute
- RECRUITINGNCT05902351Natural History Study for Charcot Marie Tooth DiseaseHereditary Neuropathy Foundation
See all trials for Autosomal dominant Charcot-Marie-Tooth disease type 2 with giant axons →